Skip to Content

90 Results Found

  • Systematic Review
  • Open Access
13 Citations
4,531 Views
28 Pages

A Review on the Bioactivity of Cannabinoids on Zebrafish Models: Emphasis on Neurodevelopment

  • Rosario Licitra,
  • Maria Marchese,
  • Valentina Naef,
  • Asahi Ogi,
  • Marco Martinelli,
  • Claudia Kiferle,
  • Baldassare Fronte and
  • Filippo Maria Santorelli

For centuries, the cannabis plant has been used as a source of food, fiber, and medicine. Recently, scientific interest in cannabis has increased considerably, as its bioactive compounds have shown promising potential in the treatment of numerous mus...

(This article belongs to the Special Issue Therapeutic Potential for Cannabis and Cannabinoids)
  • Review
  • Open Access
1,666 Views
32 Pages

Silicon (Si) is a beneficial, non-essential element used in cannabis (Cannabis sativa L.), yet cannabis-specific evidence is scattered across hemp and drug-type cannabis. Because the marketable organ in drug-type and medicinal cannabis is the inflore...

(This article belongs to the Special Issue Emerging Roles of Non-Essential Elements and Natural Compounds in High-Value Crop Growth and Stress Tolerance)
  • Review
  • Open Access
7 Citations
7,631 Views
31 Pages

Soilless Growing Media for Cannabis Cultivation

  • Matěj Malík and
  • Pavel Tlustoš

16 September 2025

Standardized pharmaceutical-grade cultivation of Cannabis sativa L. increasingly relies on soilless systems for precision, reproducibility, and regulatory compliance. This review examines the role of inert and semi-inert growing media in indoor canna...

(This article belongs to the Special Issue Agronomic Practices for Enhancing Quality and Yield of Aromatic and Medicinal Crops)
  • Article
  • Open Access
22 Citations
11,470 Views
13 Pages

Simultaneous Quantification of 17 Cannabinoids in Cannabis Inflorescence by Liquid Chromatography-Mass Spectrometry

  • Amitha K. Hewavitharana,
  • Francine Gloerfelt-Tarp,
  • Matthew Nolan,
  • Bronwyn J. Barkla,
  • Sarah Purdy and
  • Tobias Kretzschmar

With an increasing appreciation for the unique pharmacological properties associated with distinct, individual cannabinoids of Cannabis sativa, there is demand for accurate and reliable quantification for a growing number of them. Although recent met...

(This article belongs to the Special Issue Separation and Quantitative Analysis of Natural Product Extracts)
  • Review
  • Open Access
102 Citations
18,216 Views
31 Pages

Cannabis sativa L. as a Natural Drug Meeting the Criteria of a Multitarget Approach to Treatment

  • Anna Stasiłowicz,
  • Anna Tomala,
  • Irma Podolak and
  • Judyta Cielecka-Piontek

Cannabis sativa L. turned out to be a valuable source of chemical compounds of various structures, showing pharmacological activity. The most important groups of compounds include phytocannabinoids and terpenes. The pharmacological activity of Cannab...

(This article belongs to the Special Issue Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives 3.0)
  • Review
  • Open Access
10 Citations
7,275 Views
30 Pages

13 October 2024

Cannabis sativa is known for producing over 120 distinct phytocannabinoids, with Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) being the most prominent, primarily in their acidic forms. Beyond Δ9-THC and CBD, a wide array o...

(This article belongs to the Section Molecular Biology)
  • Review
  • Open Access
89 Citations
13,924 Views
24 Pages

Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use

  • Nicoleta Mirela Blebea,
  • Andreea Iulia Pricopie,
  • Robert-Alexandru Vlad and
  • Gabriel Hancu

Phytocannabinoids, a diverse group of naturally occurring compounds extracted from the Cannabis plant, have attracted interest due to their potential pharmacological effects and medicinal uses. This comprehensive review presents the intricate pharmac...

(This article belongs to the Special Issue Chemopreventive Activities of Phytochemicals 2.0)
  • Article
  • Open Access
20 Citations
6,549 Views
14 Pages

Pharmacokinetics of Orally Applied Cannabinoids and Medical Marijuana Extracts in Mouse Nervous Tissue and Plasma: Relevance for Pain Treatment

  • Cristiana Dumbraveanu,
  • Katharina Strommer,
  • Meinolf Wonnemann,
  • Jeiny Luna Choconta,
  • Astrid Neumann,
  • Michaela Kress,
  • Theodora Kalpachidou and
  • Kai K. Kummer

Cannabis sativa plants contain a multitude of bioactive substances, which show broad variability between different plant strains. Of the more than a hundred naturally occurring phytocannabinoids, Δ9-Tetrahydrocannabinol (Δ9-THC) and canna...

  • Article
  • Open Access
40 Citations
8,367 Views
16 Pages

22 October 2020

In this proof-of-concept study, the antioxidant activity of phytocannabinoids, namely cannabidiol (CBD) and Δ9- tetrahydrocannabinol (THC), were investigated using an in vitro system of differentiated human neuronal SY-SH5Y cells. The oxidative...

(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest)
  • Review
  • Open Access
41 Citations
23,784 Views
36 Pages

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

  • Nicholas Pintori,
  • Francesca Caria,
  • Maria Antonietta De Luca and
  • Cristina Miliano

Cannabis is the most used drug of abuse worldwide. It is well established that the most abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These two compounds have remarkably similar chemical struc...

(This article belongs to the Special Issue Exposure to Phytocannabinoids: Exploring Central Effects and Toxicity)
  • Article
  • Open Access
37 Citations
29,992 Views
26 Pages

Phytocannabinoids Stimulate Rejuvenation and Prevent Cellular Senescence in Human Dermal Fibroblasts

  • Marta Gerasymchuk,
  • Gregory Ian Robinson,
  • Alyssa Groves,
  • Lucie Haselhorst,
  • Sanjana Nandakumar,
  • Cora Stahl,
  • Olga Kovalchuk and
  • Igor Kovalchuk

6 December 2022

In light of the increased popularity of phytocannabinoids (pCBs) and their appearance in beauty products without rigorous research on their rejuvenation efficacy, we decided to investigate the potential role of pCBs in skin rejuvenation. Utilizing he...

(This article belongs to the Special Issue Molecular and Cell Basis of Skin Diseases and Aging)
  • Article
  • Open Access
89 Citations
13,185 Views
17 Pages

Terpenoids and Phytocannabinoids Co-Produced in Cannabis Sativa Strains Show Specific Interaction for Cell Cytotoxic Activity

  • Dvora Namdar,
  • Hillary Voet,
  • Vinayaka Ajjampura,
  • Stalin Nadarajan,
  • Einav Mayzlish-Gati,
  • Moran Mazuz,
  • Nurit Shalev and
  • Hinanit Koltai

21 August 2019

Mixtures of different Cannabis sativa phytocannabinoids are more active biologically than single phytocannabinoids. However, cannabis terpenoids as potential instigators of phytocannabinoid activity have not yet been explored in detail. Terpenoid gro...

(This article belongs to the Collection Phenolic Compounds from Plants: Chemistry, Analysis and Biological Activity)
  • Feature Paper
  • Review
  • Open Access
29 Citations
13,187 Views
24 Pages

Efficacy of Phytocannabinoids in Epilepsy Treatment: Novel Approaches and Recent Advances

  • Aaron M. Farrelly,
  • Styliani Vlachou and
  • Konstantinos Grintzalis

Epilepsy is a neurological disorder mainly characterised by recurrent seizures that affect the entire population diagnosed with the condition. Currently, there is no cure for the disease and a significant proportion of patients have been deemed to ha...

(This article belongs to the Special Issue Legal and Illegal Drug Abuse in Adolescents and Young Adults: Challenges, Comorbidities, Treatment and Use as Therapeutics)
  • Review
  • Open Access
85 Citations
24,806 Views
24 Pages

10 February 2022

The plant Cannabis sativa has been in use medicinally for several thousand years. It has over 540 metabolites thought to be responsible for its therapeutic effects. Two of the key phytocannabinoids are cannabidiol (CBD) and tetrahydrocannabinol (THC)...

(This article belongs to the Special Issue Integrated Management of Cancer)
  • Article
  • Open Access
12 Citations
6,340 Views
16 Pages

Cannabidiol Exerts Anticonvulsant Effects Alone and in Combination with Δ9-THC through the 5-HT1A Receptor in the Neocortex of Mice

  • Yasaman Javadzadeh,
  • Alexandra Santos,
  • Mark S. Aquilino,
  • Shanthini Mylvaganam,
  • Karolina Urban and
  • Peter L. Carlen

7 March 2024

Cannabinoids have shown potential in drug-resistant epilepsy treatment; however, we lack knowledge on which cannabinoid(s) to use, dosing, and their pharmacological targets. This study investigated (i) the anticonvulsant effect of Cannabidiol (CBD) a...

  • Article
  • Open Access
12 Citations
5,635 Views
22 Pages

The innate immune response to bacterial and viral molecules involves the coordinated production of cytokines, chemokines, and type I interferons (IFNs), which is orchestrated by toll-like receptors (TLRs). TLRs, and their intracellular signalling int...

(This article belongs to the Special Issue High Times for Cannabinoid Research)
  • Review
  • Open Access
5 Citations
5,679 Views
47 Pages

22 August 2023

Before the late 1980s, ideas around how the lipophilic phytocannabinoids might be working involved membranes and bioenergetics as these disciplines were “in vogue”. However, as interest in genetics and pharmacology grew, interest in mitoc...

(This article belongs to the Special Issue New Insight into Cannabinoid Effects 2.0)
  • Article
  • Open Access
51 Citations
7,143 Views
15 Pages

Cytotoxic Effects of Cannabinoids on Human HT-29 Colorectal Adenocarcinoma Cells: Different Mechanisms of THC, CBD, and CB83

  • Daniela Cerretani,
  • Giulia Collodel,
  • Antonella Brizzi,
  • Anna Ida Fiaschi,
  • Andrea Menchiari,
  • Elena Moretti,
  • Laura Moltoni and
  • Lucia Micheli

In this study, we investigated the effects of exposition to IC50 dose for 24 h of a new synthetic cannabinoid (CB83) and of phytocannabinoids Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on HT-29 colorectal carcinoma cells. Cell viabilit...

(This article belongs to the Section Molecular Pharmacology)
  • Article
  • Open Access
34 Citations
8,676 Views
8 Pages

Pharmacokinetics of Sativex® in Dogs: Towards a Potential Cannabinoid-Based Therapy for Canine Disorders

  • María Fernández-Trapero,
  • Carmen Pérez-Díaz,
  • Francisco Espejo-Porras,
  • Eva de Lago and
  • Javier Fernández-Ruiz

11 February 2020

The phytocannabinoid-based medicine Sativex® is currently marketed for the treatment of spasticity and pain in multiple sclerosis patients and is being investigated for other central and peripheral pathological conditions. It may also serve in Ve...

(This article belongs to the Special Issue The Endocannabinoid System in Health and Disease)
  • Article
  • Open Access
16 Citations
5,556 Views
19 Pages

Oxidative Stress and Multi-Organel Damage Induced by Two Novel Phytocannabinoids, CBDB and CBDP, in Breast Cancer Cells

  • Maria Salbini,
  • Alessandra Quarta,
  • Fabiana Russo,
  • Anna Maria Giudetti,
  • Cinzia Citti,
  • Giuseppe Cannazza,
  • Giuseppe Gigli,
  • Daniele Vergara and
  • Antonio Gaballo

14 September 2021

Over the last few years, much attention has been paid to phytocannabinoids derived from Cannabis for their therapeutic potential. Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD) are the most abundant compounds of the Cannabis sativa L. plant....

(This article belongs to the Special Issue Secondary Metabolites for the Reduction of Oxidative Stress)
  • Review
  • Open Access
33 Citations
8,297 Views
15 Pages

1 September 2022

Ovarian cancer (OC) is the most lethal gynecological malignancy, with about 70% of cases diagnosed only at an advanced stage. Cannabis sativa, which produces more than 150 phytocannabinoids, is used worldwide to alleviate numerous symptoms associated...

(This article belongs to the Collection Stemness and Drug-Persistence in Cancer)
  • Review
  • Open Access
111 Citations
22,064 Views
24 Pages

Cannabidiol—from Plant to Human Body: A Promising Bioactive Molecule with Multi-Target Effects in Cancer

  • Brigitta Kis,
  • Feng Chen Ifrim,
  • Valentina Buda,
  • Stefana Avram,
  • Ioana Zinuca Pavel,
  • Diana Antal,
  • Virgil Paunescu,
  • Cristina Adriana Dehelean,
  • Florina Ardelean and
  • Corina Danciu
  • + 2 authors

25 November 2019

Cannabis sativa L. is a plant long used for its textile fibers, seed oil, and oleoresin with medicinal and psychoactive properties. It is the main source of phytocannabinoids, with over 100 compounds detected so far. In recent years, a lot of attenti...

(This article belongs to the Special Issue Endocannabinoid System in Health and Disease: Current Situation and Future Perspectives)
  • Article
  • Open Access
33 Citations
5,414 Views
12 Pages

26 April 2023

Currently, there is an increased interest from both scientists and consumers in the application of cannabis/hemp/phytocannabinoids in skin-related disorders. However, most previous investigations assessed the pharmacological properties of hemp extrac...

(This article belongs to the Special Issue Bioactive Compounds from Plants and Foods with Pharmaceutical Interest 2023)
  • Article
  • Open Access
36 Citations
4,847 Views
22 Pages

27 June 2022

Phytocannabinoids represent a promising approach in glioblastoma therapy. Previous work has shown that a combined treatment of glioblastoma cells with submaximal effective concentrations of psychoactive Δ9-tetrahydrocannabinol (THC) and non-psy...

(This article belongs to the Special Issue Recent Advances in Drug Therapy for Glioblastoma)
  • Review
  • Open Access
254 Citations
75,588 Views
34 Pages

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders

  • María S. García-Gutiérrez,
  • Francisco Navarrete,
  • Ani Gasparyan,
  • Amaya Austrich-Olivares,
  • Francisco Sala and
  • Jorge Manzanares

19 November 2020

The potential therapeutic use of some Cannabis sativa plant compounds has been attracting great interest, especially for managing neuropsychiatric disorders due to the relative lack of efficacy of the current treatments. Numerous studies have been ca...

(This article belongs to the Special Issue The Endocannabinoid System in Health and Disease)
  • Review
  • Open Access
183 Citations
38,796 Views
24 Pages

21 May 2012

Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic and anti-inflammatory properties. However, up to this point, a comprehensive literature rev...

  • Review
  • Open Access
28 Citations
9,795 Views
26 Pages

Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies

  • Mariana Luz-Veiga,
  • João Azevedo-Silva and
  • João C. Fernandes

20 January 2023

The phytocannabinoid cannabidiol (CBD) is receiving increasing attention due to its pharmacological properties. Although CBD is extracted from Cannabis sativa, it lacks the psychoactive effects of Δ9-tetrahydrocannabinol (THC) and has become an...

(This article belongs to the Section Biopharmaceuticals)
  • Review
  • Open Access
37 Citations
11,293 Views
14 Pages

13 August 2010

Phytocannabinoids present in Cannabis plants are well known to exert potent anti-inflammatory and immunomodulatory effects. Previously, we have demonstrated that the psychoactive D9-tetrahydrocannabinol (THC) and the non-psychotropic cannabidiol (CBD...

(This article belongs to the Special Issue Cannabinoids)
  • Review
  • Open Access
142 Citations
22,348 Views
26 Pages

The Polypharmacological Effects of Cannabidiol

  • Jorge Castillo-Arellano,
  • Ana Canseco-Alba,
  • Stephen J. Cutler and
  • Francisco León

Cannabidiol (CBD) is a major phytocannabinoid present in Cannabis sativa (Linneo, 1753). This naturally occurring secondary metabolite does not induce intoxication or exhibit the characteristic profile of drugs of abuse from cannabis like Δ9-te...

(This article belongs to the Special Issue Improvements and Opportunities on Natural Products for Novel Drug Discovery)
  • Article
  • Open Access
1 Citations
2,602 Views
30 Pages

THC and CBD Induce Heme Oxygenase-1-Dependent Cell Death and Trigger Mitochondrial Dysfunction in Human Melanoma and Cutaneous Squamous Cell Carcinoma Cells

  • Elisabeth Thamm,
  • Felix Wittig,
  • Bianca Hamann,
  • Franziska Wendt,
  • Steffen Emmert,
  • Marcus Frank and
  • Burkhard Hinz

26 February 2026

In the search for new therapeutic strategies for the treatment of skin cancer, cannabinoids have become the focus of scientific interest. The present study investigated the effects of the phytocannabinoids Δ9-tetrahydrocannabinol (THC) and cann...

(This article belongs to the Section Health Outcomes of Antioxidants and Oxidative Stress)
  • Article
  • Open Access
13 Citations
4,886 Views
16 Pages

Single and Repeated Exposure to Cannabidiol Differently Modulate BDNF Expression and Signaling in the Cortico-Striatal Brain Network

  • Francesca Mottarlini,
  • Marco Fumagalli,
  • Fernando Castillo-Díaz,
  • Stefano Piazza,
  • Giorgia Targa,
  • Enrico Sangiovanni,
  • Barbara Pacchetti,
  • Mikael H. Sodergren,
  • Mario Dell’Agli and
  • Lucia Caffino
  • + 1 author

Cannabidiol (CBD) is a phytocannabinoid contained in the Cannabis sativa plant, devoid of psychotomimetic effects but with a broad-spectrum pharmacological activity. Because of its pharmacological profile and its ability to counteract the psychoactiv...

(This article belongs to the Special Issue Therapeutic Potential for Cannabis and Cannabinoids)
  • Article
  • Open Access
35 Citations
8,284 Views
12 Pages

Several cannabinoids afforded neuroprotection in experimental models of Huntington’s disease (HD). We investigated whether a 1:1 combination of botanical extracts enriched in either ∆9-tetrahydrocannabinol (∆9-THC) or cannabidiol (CBD), which are the...

(This article belongs to the Special Issue Cannabinoid Signaling in Nervous System)
  • Article
  • Open Access
3 Citations
1,887 Views
19 Pages

30 April 2025

Type 2 diabetes mellites (T2DM) is the most common form of diabetes and affects a significant portion of the population. Obesity-related increases in free fatty acids and glucose in the diet contribute to β-cell dysfunction and loss, ultimately...

(This article belongs to the Special Issue Bioactivity of Natural Compounds: From Plants to Humans)
  • Article
  • Open Access
15 Citations
6,100 Views
18 Pages

The widespread use of phytocannabinoids or cannabis extracts as ingredients in numerous types of products, in combination with the legal restrictions on THC content, has created a need for the development of new, rapid, and universal analytical metho...

(This article belongs to the Special Issue Synthesis, Quantification and NMR Characterization of Bioactive Compounds)
  • Article
  • Open Access
21 Citations
6,539 Views
9 Pages

Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis

  • Ana Pilar Pérez-Acevedo,
  • Francesco Paolo Busardò,
  • Roberta Pacifici,
  • Giulio Mannocchi,
  • Massimo Gottardi,
  • Lourdes Poyatos,
  • Esther Papaseit,
  • Clara Pérez-Mañá,
  • Soraya Martin and
  • Magí Farré
  • + 2 authors

12 December 2020

The use of cannabis flowering tops with standardized amounts of active phytocannabinoids was recently authorized in several countries to treat several painful pathological conditions. The acute pharmacological effects and disposition of Δ-9-tetrahydr...

  • Opinion
  • Open Access
19 Citations
12,406 Views
12 Pages

The endogenous cannabinoid system (ECS) plays a critical role in the regulation of various physiological functions, including sleep, mood, and neuroinflammation. Phytocannabinoids such as Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), cannab...

(This article belongs to the Special Issue Mechanisms of the Endocannabinoid System and Their Role in Neurophysiology and Psychopathology)
  • Feature Paper
  • Article
  • Open Access
27 Citations
19,235 Views
13 Pages

Identification and Characterization of Cannabimovone, a Cannabinoid from Cannabis sativa, as a Novel PPARγ Agonist via a Combined Computational and Functional Study

  • Fabio Arturo Iannotti,
  • Fabrizia De Maio,
  • Elisabetta Panza,
  • Giovanni Appendino,
  • Orazio Taglialatela-Scafati,
  • Luciano De Petrocellis,
  • Pietro Amodeo and
  • Rosa Maria Vitale

Phytocannabinoids (pCBs) are a large family of meroterpenoids isolated from the plant Cannabis sativa. Δ9-Tetrahydrocannabinol (THC) and cannabidiol (CBD) are the best investigated phytocannabinoids due to their relative abundance and interesti...

(This article belongs to the Special Issue Role of PPAR Receptors in Human Health and Disease)
  • Article
  • Open Access
3 Citations
1,287 Views
22 Pages

UVA and UVB Photolysis of Natural and Synthetic Cannabinoids Studied by Online Mass Spectrometry

  • Ambar S. A. Shaikh,
  • Kelechi O. Uleanya,
  • Kgato P. Selwe and
  • Caroline E. H. Dessent

28 February 2026

Cannabinoids are of considerable current interest for use in pharmaceutical and non-medical consumer products. While there have been significant efforts to understand their chemical stability under ambient conditions, only sparse attention has been p...

(This article belongs to the Special Issue Recent Advances in Cannabis and Hemp Research—2nd Edition)
  • Article
  • Open Access
12 Citations
4,168 Views
17 Pages

Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines

  • Saba Omer,
  • Suhrud Pathak,
  • Mahmoud Mansour,
  • Rishi Nadar,
  • Dylan Bowen,
  • Muralikrishnan Dhanasekaran,
  • Satyanarayana R. Pondugula and
  • Dawn Boothe

19 April 2024

In our previous study, we demonstrated the impact of overexpression of CB1 and CB2 cannabinoid receptors and the inhibitory effect of endocannabinoids (2-arachidonoylglycerol (2-AG) and Anandamide (AEA)) on canine (Canis lupus familiaris) and human (...

(This article belongs to the Special Issue New Advances of Cannabinoid Receptors in Health and Disease)
  • Review
  • Open Access
37 Citations
6,005 Views
25 Pages

Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research

  • Diego Caprioglio,
  • Hawraz Ibrahim M. Amin,
  • Orazio Taglialatela-Scafati,
  • Eduardo Muñoz and
  • Giovanni Appendino

6 August 2022

Despite the very large number of phytocannabinoids isolated from Cannabis (Cannabis sativa L.), bioactivity studies have long remained focused on the so called “Big Four” [Δ9-THC (1), CBD (2), CBG (3) and CBC (4)] because of their e...

(This article belongs to the Section Synthetic Biology and Bioengineering)
  • Article
  • Open Access
17 Citations
4,370 Views
24 Pages

Cannabidiol Protects Dopaminergic Neurons in Mesencephalic Cultures against the Complex I Inhibitor Rotenone Via Modulation of Heme Oxygenase Activity and Bilirubin

  • Johanna Catharina Duvigneau,
  • Alice Trovato,
  • Andrea Müllebner,
  • Ingrid Miller,
  • Christopher Krewenka,
  • Kristina Krenn,
  • Wilhelm Zich and
  • Rudolf Moldzio

4 February 2020

Phytocannabinoids protect neurons against stressful conditions, possibly via the heme oxygenase (HO) system. In cultures of primary mesencephalic neurons and neuroblastoma cells, we determined the capability of cannabidiol (CBD) and tetrahydrocannabi...

(This article belongs to the Special Issue Heme Oxygenase-A Balancing Act Between Cytoprotective and Pathophysiological Cascades)
  • Article
  • Open Access
15 Citations
8,091 Views
14 Pages

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most prevalent and dose-limiting complications in chemotherapy patients, with estimates of at least 30% of patients experiencing persistent neuropathy for months or years after treatment...

(This article belongs to the Special Issue Therapeutic Potential for Cannabis and Cannabinoids 2.0)
  • Review
  • Open Access
9 Citations
6,074 Views
21 Pages

Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder

  • Sean Massey,
  • Anita Quigley,
  • Simone Rochfort,
  • John Christodoulou and
  • Nicole J. Van Bergen

7 October 2024

Pediatric genetic epilepsies, such as CDKL5 Deficiency Disorder (CDD), are severely debilitating, with early-onset seizures occurring more than ten times daily in extreme cases. Existing antiseizure drugs frequently prove ineffective, which significa...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
1,353 Views
26 Pages

24 July 2026

Cannabis sativa contains more than 120 phytocannabinoids, with Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the best characterized. This review synthesizes preclinical and clinical evidence on hemp-derived extracts, cannabinoids, a...

(This article belongs to the Special Issue Neuropharmacology of Plant Extracts and Their Active Compounds (Second Edition))
  • Review
  • Open Access
16 Citations
31,286 Views
19 Pages

Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment

  • Rebeca Pérez,
  • Talita Glaser,
  • Cecilia Villegas,
  • Viviana Burgos,
  • Henning Ulrich and
  • Cristian Paz

15 December 2022

Cannabis sativa is one of the first medicinal plants used by humans. Its medical use remains controversial because it is a psychotropic drug whose use has been banned. Recently, however, some countries have approved its use, including for recreationa...

(This article belongs to the Collection COVID-19 and Life)
  • Review
  • Open Access
6 Citations
10,248 Views
22 Pages

The Cannabinoid Pharmacology of Bone Healing: Developments in Fusion Medicine

  • Gabriel Urreola,
  • Michael Le,
  • Alan Harris,
  • Jose A. Castillo,
  • Augustine M. Saiz,
  • Hania Shahzad,
  • Allan R. Martin,
  • Kee D. Kim,
  • Safdar Khan and
  • Richard Price

Background/Objectives: Cannabinoid use is rising among patients undergoing spinal fusion, yet its influence on bone healing is poorly defined. The endocannabinoid system (ECS)—through cannabinoid receptors 1 (CB1) and 2 (CB2)—modulates sk...

(This article belongs to the Topic Cannabis, Cannabinoids and Its Derivatives)
  • Article
  • Open Access
11 Citations
4,251 Views
32 Pages

Molecular Targets of Minor Cannabinoids in Breast Cancer: In Silico and In Vitro Studies

  • Cristina Ferreira Almeida,
  • Andreia Palmeira,
  • Maria João Valente,
  • Georgina Correia-da-Silva,
  • Anne Marie Vinggaard,
  • Maria Emília Sousa,
  • Natércia Teixeira and
  • Cristina Amaral

21 September 2024

Background: Breast cancer therapy has been facing remarkable changes. Classic treatments are now combined with other therapies to improve efficacy and surpass resistance. Indeed, the emergence of resistance demands the development of novel therapeuti...

(This article belongs to the Special Issue Therapeutic Potential for Cannabinoid and Its Receptor)
  • Feature Paper
  • Review
  • Open Access
52 Citations
12,466 Views
21 Pages

Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid

  • Chiara Maioli,
  • Daiana Mattoteia,
  • Hawraz Ibrahim M. Amin,
  • Alberto Minassi and
  • Diego Caprioglio

28 October 2022

Cannabis (Cannabis sativa L.) is an outstanding source of bioactive natural products, with more than 150 different phytocannabinoids isolated throughout the decades; however, studies of their bioactivity have historically concentrated on the so-calle...

(This article belongs to the Special Issue Exploring the Universe of Natural Products: Recent Advances in Synthesis, Isolation and Structural Elucidation II)
  • Review
  • Open Access
91 Citations
14,450 Views
15 Pages

The Origin and Biomedical Relevance of Cannabigerol

  • Anna Jastrząb,
  • Iwona Jarocka-Karpowicz and
  • Elżbieta Skrzydlewska

The constant search for new pharmacologically active compounds, especially those that do not exhibit toxic effects, intensifies the interest in plant-based ingredients and their potential use in pharmacotherapy. One of the plants that has great thera...

(This article belongs to the Special Issue New Insight into Cannabinoid Effects)
  • Review
  • Open Access
9 Citations
7,328 Views
46 Pages

Due to the rapid emergence of multi drug resistant (MDR) pathogens against which current antibiotics are no longer functioning, severe infections are becoming practically untreatable. Consequently, the discovery of new classes of effective antimicrob...

(This article belongs to the Special Issue Focus on Antibiotics – New Challenges and Steps Forward in Discovery and Development, 2nd Edition)

of 2